Looking ahead: A case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy

International Journal of Cancer

Volumn 129, Issue 3, 2011, Pages 517-527

  Gravitt, Patti E ^a   Belinson, Jerome L ^b   Salmeron, Jorge ^c   Shah, Keerti V ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

cervical cancer; HPV; papillomavirus; screening; self sampling

Indexed keywords

CANCER SCREENING; CLINICAL OBSERVATION; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FOLLOW UP; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HUMAN; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CYTOLOGY; VAGINA SMEAR; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 79958052476     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25974     Document Type: Review

References (76)

1. Koutsky LA, Harper DM,. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine 2006; 24: S114-21. (Pubitemid 44293027)
2. Kitchener HC, Castle PE, Cox JT,. Chapter 7: achievements and limitations of cervical cytology screening. Vaccine 2006; 24: S63-70. (Pubitemid 44308671)
3. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC, Jr,. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89: 826-33. (Pubitemid 30658582)
4. Denny L, Quinn M, Sankaranarayanan R,. Chapter 8: screening for cervical cancer in developing countries. Vaccine 2006; 24: S71-7. (Pubitemid 44293035)
5. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet 1999; 353: 869-73.
6. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC, Jr,. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294: 2173-81. (Pubitemid 41571134)
7. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette J-M, Cherian J,. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370: 398-406. (Pubitemid 47176655)
8. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
9. Mahe C, Gaffikin L,. Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening. Cancer Causes Control 2005; 16: 657-66. (Pubitemid 41110956)
10. Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008; 123: 153-60. (Pubitemid 351705203)
11. Vedantham H, Silver MI, Kalpana B, Rekha C, Karuna BP, Vidyadhari K, Mrudula S, Ronnett BM, Vijayaraghavan K, Ramakrishna G, Sowjanya P, Laxmi S, et al. Determinants of VIA (visual inspection of the cervix after acetic acid application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2010; 19: 1373-80.
12. Chamot E, Kristensen S, Stringer J, Mwanahamuntu M,. Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review. BMC Women's Health 2010; 10: 11.
13. Meijer CJLM, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DAM, Snijders PJF,. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-20.
14. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
15. Wright TC, Jr, Denny L, Kuhn L, Pollack A, Lorincz A,. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-6. (Pubitemid 30038387)
16. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13: 819-26. (Pubitemid 38235227)
17. Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14: 505-12. (Pubitemid 36999965)
18. Sowjanya AP, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D, Vijayaraghavan K, Laksmi S, Sudula M, Ronnett BM, Das M, Shah KV, Gravitt PE,. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2009; 18: 1373-8.
19. Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE,. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009; 33: 446-50.
20. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D,. Shanxi Province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 439-44. (Pubitemid 33033096)
21. Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F,. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007; 105: 530-5. (Pubitemid 46590347)
22. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, Arias C, Manetta A,. Self-sampling for human papillomavirus in a community setting: feasibility in hispanic women. Cancer Epidemiol Biomarkers Prev 2008; 17: 2163-8.
23. Khanna N, Mishra S, Tian G, Tan M, Arnold S, Lee C, Ramachandran S, Bell L, Baquet C,. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. Int J Gynecol Cancer 2007; 17: 615-22. (Pubitemid 46744000)
24. Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R,. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. [Article]. Sexually Transmit Dis 2007; 34: 429-36. (Pubitemid 46987946)
25. Holanda JF, Castelo A, Veras TMCW, de Almeida FML, Lins MZ, Dores GB,. Primary screening for cervical cancer through self sampling. Int J Gynecol Obstet 2006; 95: 179-84. (Pubitemid 44635514)
26. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J,. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sexually Transmit Infect 2006; 82: 337-9. (Pubitemid 44229454)
27. Qiao Y-L, Sellors JW, Eder PS, Bao Y-P, Lim JM, Zhao F-H, Weigl B, Zhang W-H, Peck RB, Li L, Chen F, Pan Q-J, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-36.
28. Jones HE, Allan BR, van de Wijgert JHHM, Altini L, Taylor SM, de Kock A, Coetzee N, Williamson A-L,. Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol 2007; 45: 1679-83. (Pubitemid 46933891)
29. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, Wardle J, Altman DG, Cuzick J,. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007; 14: 34-42. (Pubitemid 46440364)
30. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD,. A comparison of cervical and vaginal human papillomavirus. Sexually Transmit Dis 2007; 34: 849-55. 10.1097/OLQ. 0b013e318064c8c5. (Pubitemid 350301046)
31. Gravitt PE, Lacey JV, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001; 10: 95-100. (Pubitemid 32172426)
32. Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao Y-L,. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 2010; 127: 1151-7.
33. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT,. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000; 283: 87-93. (Pubitemid 30038388)
34. Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL,. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. New Engl J Med 2007; 357: 1579-88. (Pubitemid 47598400)
35. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M,. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008; 46: 2595-604.
36. Wu R, Du H, Belinson S, Yang B, Qu X, Wang C, Wu R, Wang G, Yang G, Belinson J,. The Shenzhen cervical cancer screening trial II (SHENCCAST II). Presented at IPV 2010, Montreal, Canada, 2010.
37. Belinson J, Du H, Yang B, Belinson S, Qu X, Castle PE, Pretorius R, Wang C, Yang G, Wu R,. Prospective randomized comparison of the POI/NIH and the Qiagen self-sampling brushes. Presented at IPV 2010, Montreal, Canada, 2010.
38. Nieves L, Enerson C, Belinson S, Booth C, Brainard J, Chiesa-Vottero A, Perez A, Belinson J,. Mexican cervical cancer screening study II (MECCS II). Presented at Eurogin 2010, Monte Carlo, 2010.
39. Soisson AP, Reed E, Brown P, Ducatman B, Armistead J, Kennedy S, Wang W, Kramer P, Rose S,. Self-test device for cytology and HPV testing in rural Appalachian women: an evaluation. J Reprod Med 2008; 53: 441-8. (Pubitemid 351976417)
40. Rompalo Anne M, Gaydos Charlotte A, Shah N, Tennant M, Crotchfelt Kimberly A, Madico G, Quinn Thomas C, Daniel R, Shah Keerti V, Gaydos Joel C, McKee J, Kelly T,. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001; 33: 1455-61. (Pubitemid 34246136)
41. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC,. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Women Health 2005; 14: 721-8. (Pubitemid 41645634)
42. Moscicki A-B, Widdice L, Ma Y, Farhat S, Miller-Benningfield S, Jonte J, Jay J, Medina CGd, Hanson E, Clayton L, Shiboski S,. Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling. Int J Cancer 2010; 9999:NA.
43. Brown Darron R, Shew Marcia L, Qadadri B, Neptune N, Vargas M, Tu W, Juliar Beth E, Breen Timothy E, Fortenberry JD,. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191: 182-92. (Pubitemid 40096375)
44. Safaeian M, Kiddugavu M, Gravitt PE, Gange SJ, Ssekasanvu J, Murokora D, Sklar M, Serwadda D, Wawer MJ, Shah KV, Gray R,. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008; 17: 1300-7.
45. Dzuba IG, Díaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV, Bishai D, Lorincz A, Ferris D, Turnbull B, Hernández Avila M, Salmerón J,. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Women Health Gender-Based Med 2002; 11: 265-75.
46. Tisci SM, Shen YHM, Fife DR, Huang JMM, Goycoolea JM, Ma CPM, Belinson JM, Huang R-DMD, Qiao YLMDP,. Patient acceptance of self-sampling for human papillomavirus in rural China. J Low Genit Tract Dis 2003; 7: 107-16. (Pubitemid 36469358)
47. Harper DM, Noll WW, Belloni DR, Cole BF,. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed-biologic concordance and women's preferences. Am J Obstet Gynecol 2002; 186: 365-73. (Pubitemid 34234143)
48. Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P,. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol 2004; 15: 863-9. (Pubitemid 39004340)
49. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V,. Self-collected samples fortesting of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Cancer 2007; 29: 817-28.
50. Gustavsson I, Lindell M, Wilander E, Strand A, Gyllensten U,. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol 2009; 46: 112-6.
51. Lenselink CH, de Bie RP, van Hamont D, Bakkers JMJE, Quint WGV, Massuger LFAG, Bekkers RLM, Melchers WJG,. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol 2009; 47: 2564-70.
52. Huang S, Tang N, Mak W-B, Erickson B, Salituro J, Li Y, Krumpe E, Schneider G, Yu H, Robinson J, Abravaya K,. Principles and analytical performance of Abbott realtime high risk HPV test. J Clin Virol 2009; 45: S13-7.
53. Jeantet D, Schwarzmann F, Tromp J, Melchers WJG, van der Wurff AAM, Oosterlaken T, Jacobs M, Troesch A,. NucliSENS® EasyQ® HPV v1 test-testing for oncogenic activity of human papillomaviruses. J Clin Virol 2009; 45: S29-37.
54. Dockter J, Schroder A, Eaton B, Wang A, Sikhamsay N, Morales L, Giachetti C,. Analytical characterization of the APTIMA® HPV Assay. J Clin Virol 2009; 45: S39-47.
55. Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, Chehak L, Quigley N, Ledford J, Yen-Lieberman B, Kohn D, Quigley DI, et al. Analytical performance of the investigational use only Cervista(TM) HPV HR test as determined by a multi-center study. J Clin Virol 2009; 45: S63-72.
56. Stillman MJ, Day SP, Schutzbank TE,. A comparative review of laboratory-developed tests utilizing Invader® HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virol 2009; 45: S73-7.
57. Thai H, Rangwala S, Gay T, Keating K, McLeod S, Nazarenko I, O'Neil D, Pfister D, Loeffert D. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture® technology. J Clin Virol 2009; 45: S93-7.
58. van Ham MAPC, Bakkers JMJE, Harbers GK, Quint WGV, Massuger LFAG, Melchers WJG,. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: Validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 2005; 43: 2662-7. (Pubitemid 40827937)
59. Molden T, Kraus I, Skomedal H, Nordstrøm T, Karlsen F,. PreTect(TM) HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Meth 2007; 142: 204-12. (Pubitemid 46590424)
60. Soderlund-Strand A, Dillner J, Carlson J,. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin Chem 2008; 54: 86-92. (Pubitemid 351182600)
61. Lazcano-Ponce E, Lörincz A, Salmerón J, Fernández I, Cruz A, Hernández P, Mejia I, Hernández-Úvila M,. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Cancer Causes Control 2010; 21: 1693-700.
62. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX,. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9. (Pubitemid 46962343)
63. Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WGV, Wheeler CM,. New technologies in cervical cancer screening. Vaccine 2008; 26: K42-52.
64. Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B,. p16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005; 37: 112-24. (Pubitemid 40593402)
65. Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T,. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing. Cancer Cytopathol 2004; 102: 100-8.
66. Wentzensen N, Bergeron C, Cas F, Eschenbach D, Vinokurova S, von Knebel Doeberitz M,. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer Cytopathol 2005; 105: 461-7. (Pubitemid 43067004)
67. Mao C, Balasubramanian A, Yu M, Kiviat N, Ridder R, Reichert A, Herkert M, Doeberitz MvK, Koutsky LA,. Evaluation of a new p16INK4A ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study. Int J Cancer 2007; 120: 2435-8. (Pubitemid 46642131)
68. Schweizer J, Lu P, Berard-Bergery M, Bisht A, Labiad Y, Ho M, Mahoney C, Ramasamy V, Silver J, Peck R, LIm J, Jeronimo J, et al. A feasability study of a human papillomavirus E6 oncoprotein test for detection of cervical precancer and cancer. J Clin Microbiol 2010; 48: 4646-8
69. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M,. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9. (Pubitemid 41417924)
70. Gage JC, Rodriguez AC, Schiffman M, Garcia FM, Long RL, Budihas SR, Herrero R, Burk RD, Jeronimo J,. Treatability by cryotherapy in a screen-and-treat strategy. J Low Genit Tract Dis 2009; 13: 174-81.
71. Gravitt P, Paul P, Katki H, Vendantham H, Ramakrishna G, Sudula M, Kalpana B, Ronnett B, Vijayaraghavan K, Shah K,. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoSONE 2010; 5: e137111.
72. Hacker M, Peterson M, Enriquez M, Bastos F,. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality. Rev Panam Salud Publica 2004; 16: 78-83. (Pubitemid 39223271)
73. Bastos F, Kerrigan D, Malta M, Carneiro-da-Cunha C, Strathdee S,. Treatment for HIV/AIDS in Brazil: strengths, challenges and opportunities for operations research. AIDScience 2001; 1: 1-17.
74. Goldie SJ, Kim JJ, Myers E,. Chapter 19: cost-effectiveness of cervical cancer screening. Vaccine 2006; 24: S164-70. (Pubitemid 44293023)
75. WHO. Comprehensive cervical cancer control: a guide to essential practice. Geneva: World Health Organization, 2006.
76. Gakidou E, Nordhagen S, Obermeyer Z,. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008; 5: 863-8.